Abstract
The total cases of randomized controlled trials (RCT) from the 1950s in the area of medicine and healthcare have exceeded 600,000. Interest in RCT has been increasing since the mid-1990s with the global movement of evidence-based medicine (EBM). Several problems were identified in the EBM movement, leading to the development of new solutions. It was found that these problems were discovered at “use” and “cascading evidence” stages rather than the “generate” stage of the evidence usage whose categories were introduced in the previous reports. This report introduces CONSORT statements for the improvement in quality of RCT reports and their utilization in many aspects at the “stream down” stage. Feedback from narrative based information and the informative best case as one of the current movements of post-RCT at the “use” stage are also discussed. Furthermore, the latest trends toward the need for continuous evaluation of public investment, and the patient's and the citizen's roles in EBM development are discussed.
